FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379879991> ?p ?o ?g. }

• W4379879991 abstract "Over the past seven decades, significant advancements and innovations have occurred in the field of percutaneous atrial septal defect (ASD) closure using transcatheter-based devices. This article focuses on the current literature surrounding the three Food and Drug Administration (FDA)-approved devices for ASD and patent foramen ovale (PFO) closure in the United States, namely, the Amplatzer Septal Occluder (ASO), Amplatzer Cribriform Occluder, and Gore Cardioform ASD Occluder. The ASO has been widely used since its FDA approval in 2001. Studies have shown its high success rate in closing ASDs, especially small-sized defects. The RESPECT trial demonstrated that PFO closure using the ASO reduced the risk of recurrent ischemic stroke compared to medical therapy alone. The Closure of Atrial Septal Defects With the Amplatzer Septal Occluder Post-Approval Study (ASD PMS II) evaluated the safety and effectiveness of ASO in a large cohort of patients, reporting a high closure success rate and rare hemodynamic compromise. The Amplatzer Cribriform Occluder is designed for the closure of multifenestrated ASDs and has shown promising results in small-scale studies. It successfully closed the majority of fenestrated ASDs, leading to improved right ventricular diastolic pressure without major complications. The REDUCE trial compared PFO closure using the Gore Helex Septal Occluder and Gore Cardioform Septal Occluder with antiplatelet therapy alone. The study demonstrated that PFO closure significantly reduced the risk of recurrent stroke and brain infarction compared to antiplatelet therapy alone. However, the closure group had a higher incidence of atrial fibrillation or atrial flutter. There is a risk of atrial fibrillation with the use of ASO as well. The FDA-approved Gore Cardioform ASD Occluder showed excellent performance in the ASSURED clinical study. The device achieved high technical success and closure rates, with low rates of serious adverse events and device-related complications. A meta-analysis comparing transcatheter ASD closure with surgical closure revealed that the transcatheter approach had a high success rate, lower rates of adverse events, and shorter hospital stays compared to surgery, without any mortality. Complications associated with transcatheter ASD closure have been reported, including femoral arteriovenous fistulas, device embolization, cardiac erosion, aortic incompetence, and new-onset migraine. However, these complications are relatively rare. In conclusion, transcatheter ASD closure using FDA-approved devices has proven to be safe and effective in the majority of cases. These devices offer excellent closure rates, reduced risk of recurrent stroke, and shorter hospital stays compared to surgery. However, careful patient selection and follow-up are necessary to minimize complications and ensure optimal outcomes." @default.
• W4379879991 created "2023-06-09" @default.
• W4379879991 creator A5049767764 @default.
• W4379879991 creator A5062054337 @default.
• W4379879991 creator A5072916208 @default.
• W4379879991 creator A5082448900 @default.
• W4379879991 date "2023-06-08" @default.
• W4379879991 modified "2023-09-25" @default.
• W4379879991 title "Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices" @default.
• W4379879991 cites W1561143501 @default.
• W4379879991 cites W1561207429 @default.
• W4379879991 cites W1859495753 @default.
• W4379879991 cites W1987659490 @default.
• W4379879991 cites W1994531454 @default.
• W4379879991 cites W2012517517 @default.
• W4379879991 cites W2016511093 @default.
• W4379879991 cites W2020465567 @default.
• W4379879991 cites W2039224210 @default.
• W4379879991 cites W2042409257 @default.
• W4379879991 cites W2053691555 @default.
• W4379879991 cites W2110357411 @default.
• W4379879991 cites W2110633390 @default.
• W4379879991 cites W2110851709 @default.
• W4379879991 cites W2144345572 @default.
• W4379879991 cites W2321405882 @default.
• W4379879991 cites W2345051261 @default.
• W4379879991 cites W2743949925 @default.
• W4379879991 cites W2755497194 @default.
• W4379879991 cites W2755964661 @default.
• W4379879991 cites W2806832430 @default.
• W4379879991 cites W2886645087 @default.
• W4379879991 cites W2943825576 @default.
• W4379879991 cites W3000442051 @default.
• W4379879991 cites W3082407224 @default.
• W4379879991 cites W3133687316 @default.
• W4379879991 cites W3166754354 @default.
• W4379879991 cites W3212876655 @default.
• W4379879991 cites W4281707343 @default.
• W4379879991 cites W4378737830 @default.
• W4379879991 doi "https://doi.org/10.7759/cureus.40132" @default.
• W4379879991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37425612" @default.
• W4379879991 hasPublicationYear "2023" @default.
• W4379879991 type Work @default.
• W4379879991 citedByCount "0" @default.
• W4379879991 crossrefType "journal-article" @default.
• W4379879991 hasAuthorship W4379879991A5049767764 @default.
• W4379879991 hasAuthorship W4379879991A5062054337 @default.
• W4379879991 hasAuthorship W4379879991A5072916208 @default.
• W4379879991 hasAuthorship W4379879991A5082448900 @default.
• W4379879991 hasBestOaLocation W43798799911 @default.
• W4379879991 hasConcept C126322002 @default.
• W4379879991 hasConcept C127413603 @default.
• W4379879991 hasConcept C141071460 @default.
• W4379879991 hasConcept C164705383 @default.
• W4379879991 hasConcept C2776893843 @default.
• W4379879991 hasConcept C2778292772 @default.
• W4379879991 hasConcept C2779161974 @default.
• W4379879991 hasConcept C2780645631 @default.
• W4379879991 hasConcept C2780813298 @default.
• W4379879991 hasConcept C71924100 @default.
• W4379879991 hasConcept C78519656 @default.
• W4379879991 hasConceptScore W4379879991C126322002 @default.
• W4379879991 hasConceptScore W4379879991C127413603 @default.
• W4379879991 hasConceptScore W4379879991C141071460 @default.
• W4379879991 hasConceptScore W4379879991C164705383 @default.
• W4379879991 hasConceptScore W4379879991C2776893843 @default.
• W4379879991 hasConceptScore W4379879991C2778292772 @default.
• W4379879991 hasConceptScore W4379879991C2779161974 @default.
• W4379879991 hasConceptScore W4379879991C2780645631 @default.
• W4379879991 hasConceptScore W4379879991C2780813298 @default.
• W4379879991 hasConceptScore W4379879991C71924100 @default.
• W4379879991 hasConceptScore W4379879991C78519656 @default.
• W4379879991 hasLocation W43798799911 @default.
• W4379879991 hasLocation W43798799912 @default.
• W4379879991 hasLocation W43798799913 @default.
• W4379879991 hasOpenAccess W4379879991 @default.
• W4379879991 hasPrimaryLocation W43798799911 @default.
• W4379879991 hasRelatedWork W2027345995 @default.
• W4379879991 hasRelatedWork W2047344647 @default.
• W4379879991 hasRelatedWork W2078105309 @default.
• W4379879991 hasRelatedWork W2085641168 @default.
• W4379879991 hasRelatedWork W2266993741 @default.
• W4379879991 hasRelatedWork W2398888823 @default.
• W4379879991 hasRelatedWork W2409916269 @default.
• W4379879991 hasRelatedWork W2595704116 @default.
• W4379879991 hasRelatedWork W4243134933 @default.
• W4379879991 hasRelatedWork W2149652125 @default.
• W4379879991 isParatext "false" @default.
• W4379879991 isRetracted "false" @default.
• W4379879991 workType "article" @default.